KRAS and cancer: Given the complex roles of microRNAs as “fine tuners” of gene expression [62], it is conceivable that the microRNA expression profile of ALK-rearranged cancers might be at least partially different from EGFR- and KRAS-driven cancers, which partly share signaling pathways.